Results OverviewBookings, which reflects the value of executed contracts for software, hardware, professional services and managed services, was $1.81 billion in the third quarter of 2021, which is an increase of 23% compared to $1.47 billion in the third quarter of 2020.• The third quarter of 2021 includes a $45 million increase in revenues due to contributions from our April 1, 2021 acquisition of the Kantar Health business.27 Table of ContentsThe following table presents a summary of our operating segment information for the third quarters of 2021 and 2020: Domestic Segment • Revenues increased 4% to $1.29 billion in the third quarter of 2021, from $1.23 billion in the same period of 2020.◦ The third quarter of 2021 includes a $21 million increase in revenues due to contributions from our April 1, 2021 acquisition of the Kantar Health business.29 Table of Contents • The first nine months of 2021 includes a $90 million increase in revenues due to contributions from our April 1, 2021 acquisition of the Kantar Health business.• The first nine months of 2021 includes a $44 million reduction in revenues due to the sale of certain of our revenue cycle outsourcing business operations to affiliates of R 1 RCM Inc., on August 3, 2020.Costs of RevenueCosts of revenue as a percent of revenues were 17% in the first nine months of both 2021 and 2020.Operating ExpensesTotal operating expenses increased 6% to $3.08 billion in the first nine months of 2021, compared to $2.89 billion in the same period of 2020.• Sales and client service expenses as a percent of revenues were 46% in the first nine months of both 2021 and 2020.These expenses increased 5% to $2.00 billion in the first nine months of 2021, from $1.91 billion in the same period of 2020.• Software development expenses as a percent of revenues were 15% in the first nine months of 2021, compared to 13% in the same period of 2020.• Amortization of acquisition-related intangibles as a percent of revenues was 1% in the first nine months of both 2021 and 2020.These expenses increased 7% to $46 million in the first nine months of 2021, from $43 million in the same period in 2020.Gain on Sale of BusinessesThe first nine months of 2020 includes a $217 million gain recognized in connection with the divestiture transactions described above.Non-Operating Items • Other income (loss), net was a net loss of $6 million in the first nine months of 2021, compared to $78 million of income in the same period of 2020.Operations by SegmentThe following table presents a summary of our operating segment information for the first nine months of 2021 and 2020: Domestic Segment • Revenues increased 4% to $3.77 billion in the first nine months of 2021, from $3.65 billion in the same period of 2020.31 Table of Contents ◦ The first nine months of 2021 includes a $42 million increase in revenues due to contributions from our April 1, 2021 acquisition of the Kantar Health business.◦ The first nine months of 2021 includes a $44 million reduction in revenues due to the sale of certain of our revenue cycle outsourcing business operations to affiliates of R 1 RCM Inc., on August 3, 2020.• Costs of revenue as a percent of revenues were 18% in the first nine months of both 2021 and 2020.• Operating expenses as a percent of revenues were 48% in the first nine months of 2021, compared to 47% in the same period of 2020.These expenses increased 4% to $1.80 billion in the first nine months of 2021, from $1.72 billion in the same period of 2020.International Segment • Revenues increased 16% to $538 million in the first nine months of 2021, from $465 million in the same period of 2020.The following factors impacted the year-over-year change in International revenues: ◦ The first nine months of 2021 includes a $48 million increase in revenues due to contributions from our April 1, 2021 acquisition of the Kantar Health business.• Costs of revenue as a percent of revenues were 15% in the first nine months of 2021, compared to 13% in the same period of 2020.• Operating expenses as a percent of revenues were 38% in the first nine months of 2021, compared to 39% in the same period of 2020.These expenses increased 13% to $207 million in the first nine months of 2021, from $183 million in the same period of 2020.Other Costs and Expenses, NetThese expenses increased 9% to $1.07 billion in the first nine months of 2021, from $985 million in the same period of 2020.The following table summarizes our cash flows in the first nine months of 2021 and 2020: Cash from Operating ActivitiesCash flows from operations increased $330 million in the first nine months of 2021 when compared to the same period of 2020, due primarily to increased collections of client receivables.During the first nine months of 2021, we paid $363 million of purchase price consideration in connection with our acquisition of Kantar Health, as further discussed in Note (2) of the Notes.During the first nine months of 2020, we received proceeds of $229 million in connection with certain business divestitures discussed above.During the first nine months of 2021, we received proceeds of $9 million in connection with the sale of our Oaks Campus.